| Application no. and date | 19750131.5 (espacenet) (Federated) (European Patent Register), 20190815 | | Patent/reg. no. and date | DK/EP 3836912, 20240501 | | Publication date | 20210623 | | Priority no. and date | EP 18189194, 20180815 | | EP pub. no. and date |
EP 3836912 20210623 | | Effective date | | | Applicant/owner | Pharmacyl AB, Svalvägen 9
237 36 Bjärred, SE | | Applicant ref. no. | | | Inventor | Björk, Anders, Svalvägen 9
23736 Bjärred, SE,
HEDLUND, Gunnar, Gullregnsvägen 131 E
224 56 LUND, SE | | Representative | | | Opponent | | | IPC Class | A61K 31/166 (2006.01) , A61K 31/196 (2006.01) , A61K 31/655 (2006.01) , A61P 1/04 (2006.01) , A61P 19/02 (2006.01) , A61P 29/00 (2006.01) , A61P 37/06 (2006.01) | | Title | A NEW MEDICAL TREATMENT FOR PATHOLOGIC INFLAMMATION | | Int. application no. | EP2019071903 | | Int. publication no. | WO2020035554 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
